IBM and the University Hospital Zurich have developed an online tool for predicting outcomes of a patient with polytrauma, the . The three predicted outcomes are Systemic Inflammatory Response Syndrome (SIRS) and sepsis within 21 days as well as early death within 72 hours since the admission of the patient. The validated offers insights into the most common laboratory parameters, such as procalcitonin (PCT).
View Article and Find Full Text PDFThe is an outcome prediction tool invented by the University Hospital of Zurich in collaboration with IBM, representing an artificial intelligence application to predict the most adverse outcome scenarios in polytrauma patients: Systemic Inflammatory Respiratory Syndrome (SIRS), sepsis within 21 days and death within 72 h. The hypothesis was how lactate values woud be associated with the incidence of sepsis. Data from 3653 patients in an internal database, with ongoing implementation, served for analysis.
View Article and Find Full Text PDFObjective: To report the outcomes of active surveillance (AS) for low-risk prostate cancer (PCa) in a single-center cohort.
Patients And Methods: This is a prospective, single-center, observational study. The cohort included all patients who underwent AS for PCa between December 1999 and December 2020 at our institution.
The University Hospital Zurich together with IBM invented an outcome prediction tool based on the IBM Watson technology, the . This tool is an artificial intelligence to predict three outcome scenarios in polytrauma patients: the Systemic Inflammatory Response Syndrome (SIRS) and sepsis within 21 days as well as death within 72 h. The knowledge of a patient's future under standardized trauma treatment might be of utmost importance.
View Article and Find Full Text PDFUnlabelled: Big data-based artificial intelligence (AI) has become increasingly important in medicine and may be helpful in the future to predict diseases and outcomes. For severely injured patients, a new analytics tool has recently been developed (WATSON Trauma Pathway Explorer) to assess individual risk profiles early after trauma. We performed a validation of this tool and a comparison with the Trauma and Injury Severity Score (TRISS), an established trauma survival estimation score.
View Article and Find Full Text PDF